Biomarkers of Cervical Spondylotic Myelopathy

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: Yes

Enrollment: 50

Sponsor: University of California, San Francisco

Summary

We believe that patients with cervical spondylotic myelopathy (CSM) have measurable changes in certain molecules in their blood compared with people without CSM. We expect that these changes may be related to how severe a patient's condition is based on imaging and clinical exams. We will also study how these molecules change before and after surgery to see whether they are related to how well patients recover. By combining these blood markers with clinical and imaging information, we hope to develop a tool that may help predict patient outcomes.

Eligibility Criteria

Healthy Inclusion Criteria: Adults over age of 18. No neck pain, radiculopathy, or myelopathy symptoms. No trauma in the past 6 months. Does not meet exclusion criteria. CSM Inclusion Criteria: All Adults over age of 18. Diagnosis of/encompassed by/related to cervical spondylotic myelopathy, cervical myelopathy, ossification of posterior longitudinal ligament. Exclusion Criteria: Age \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07772297). StuddyBuddy aggregates publicly available trial information.